NCT00775320 Assessment of Suspected Intracranial Malignancy Using 3'-Deoxy-3'18 F-flourothymidine PET Status TERMINATED Phase N/A
NCT00763750 PPX, Temozolomide, and Concurrent Radiation for Newly Diagnosed Brain Tumors Status COMPLETED Phase PHASE2
NCT00760409 Differentiating Recurrent Brain Tumor Versus Radiation Injury Using MRI Status COMPLETED Phase N/A
NCT00748774 Brain Tumor Patient-Caregiver Congruence, MD Anderson Symptom Inventory-Brain Tumor Module (MDASI-BT) Status COMPLETED Phase N/A
NCT00747253 Monteris AutoLITTâ„¢ FIM Safety Trial for Recurrent/Progressive Brain Tumors Status COMPLETED Phase PHASE1
NCT00720837 Magnetic Resonance Temperature Imaging & Imaging-Guided Laser Induced Thermal Therapy for Treatment of Metastatic Brain Tumors Status TERMINATED Phase NA
NCT00716976 Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy Status COMPLETED Phase PHASE3
NCT00597402 Avastin in Combination With Radiation (XRT) & Temozolomide, Followed by Avastin, Temozolomide and Irinotecan for Glioblastoma (GBM) and Gliosarcomas Status COMPLETED Phase PHASE2
NCT00594633 Adjunctive Donepezil Therapy and Genetic Risk Factors of Cognitive Dysfunction in Brain Tumor Survivors Status COMPLETED Phase PHASE1
NCT00584883 A Phase I Study of ABT 510 for Newly Diagnosed Glioblastoma Multiforme Status COMPLETED Phase PHASE1
NCT00555711 Monitoring Neural Tissues Properties by Modulated Imaging (MI) Status WITHDRAWN Phase N/A
NCT00503204 Phase I : Cediranib in Combination With Lomustine Chemotherapy in Recurrent Malignant Brain Tumour Status COMPLETED Phase PHASE1
NCT00498719 Cognitive Training in Attenuating Attention Deficits/Child Treatment for Cancer Status UNKNOWN Phase N/A
NCT00488644 Combined Levothyroxine/Liothyronine Supplementation in Hypothyroid Patients With Brain Tumors Status TERMINATED Phase NA
NCT00440570 A Study of Therapeutic Amplitude-modulated Electromagnetic Fields in Advanced Tumors Status COMPLETED Phase EARLY_PHASE1
NCT00418691 Effects of Methylphenidate Versus Sustained Release Methylphenidate on Cognitive Functioning Status TERMINATED Phase PHASE3